Renavotio, Inc. (OTCQB: RIII) is a holding company with internationally-recognized businessman, veteran entrepreneur and original Shark Tank investor, Kevin Harrington, on its Advisory Board. RIII is an infrastructure play and the Company intends to acquire infrastructure companies with Personal Protection Equipment sales and manufacturing, utility construction, consulting/operational agreements with small towns or county CO-OPS that operate their own water and sewer systems, providing long-term savings, utilizing smart-utility monitoring, and dedicated engineering and service personnel.

These platforms capture utility data from hand-held GPS devices or in-place sensors, with planned use of drones to identify waste contamination, leak detection, and topographic underground utility installation planning.  The infrastructure business is big business and there are a slew of small to mid-sized companies for RIII to acquire. According to a June 9, 2020 article in Forbes, "The $3.6 trillion annual global infrastructure market is one of the most important, complex, challenging - and potentially rewarding - markets in the world.  Read more about Reavotio, Inc. in our Special Report.

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) isn't just another CBD stock. RTSL is a CBD stock with some serious potential. First, let's look at the basics. RTSL is a fully-reporting company with the U.S. Securities and Exchange Commission. This innovative biotech company specializes in aerosol delivery of legal cannabinoids to the systemic blood stream though the pulmonary route of administration, which means you inhale it into your lungs. RTSL's main product is the Rxoid metered dose inhaler (MDI). The Rxoid MDI shares many similar physical characteristics to an asthma inhaler and works the same way by delivering medication directly to a user's blood stream through the pulmonary tract.

Rapid Therapeutic Science Laboratories, Inc. started trading publicly around the end of 2019 and is the low-float play most investors are looking for. With 200,000,000 authorized, RTSL has 156,856,000 issued and outstanding, as of May 6, 2020. Of the 156,856,000 issued and outstanding, 141,000,000 are restricted, 15,856,000 shares are unrestricted, and only 26,000 (not a typo) shares are held in DTC. Read more about Rapid Therapeutic Science Laboratories, Inc. in our Report.

Ealixir Inc. (OTC: EAXR) is an artificial intelligence company specializing in the management and protection of digital identity and computer technology rights. By providing individuals and businesses with the ability to control and edit information posted on the internet, EAXR helps its customers manage their online identity. The Company provides its customers the opportunity to choose the links that appear when someone searches for them on an internet search engine.

Based in Milan, Italy, EAXR currently has offices in 25 countries, including 18 operational offices and 7 representative offices. EAXR has provided service to over 500 clients worldwide, none of whom have exercised their right to have their application fee refunded. On an unaudited basis, EAXR generated annual revenues of $5,650,350 and net profits of $1,171,728 for the fiscal year ended December 31, 2019. Revenues for the fiscal year ending year ending December 31, 2018 were $1,346,872 with a net loss of $19,835.  Read more about Ealixir Inc. in our Special Report.